| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/2009 | EP2044951A1 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044949A1 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 04/08/2009 | EP2044948A1 Methods and compositions concerning poxviruses and cancer |
| 04/08/2009 | EP2044934A1 Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof |
| 04/08/2009 | EP2044851A1 Prevention of allergy at weaning |
| 04/08/2009 | EP2044195A2 Matrix and method for isolation of hepatic progenitor cells |
| 04/08/2009 | EP2044116A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease |
| 04/08/2009 | EP2044113A2 Glucagon-like peptides and uses thereof |
| 04/08/2009 | EP2044104A2 Polypeptides from neisseria meningitidis |
| 04/08/2009 | EP2044101A2 Aminothiazole derivatives and their uses as antibacterial agents |
| 04/08/2009 | EP2044097A2 Modified ribonucleases |
| 04/08/2009 | EP2043693A1 N-terminal polysialylation |
| 04/08/2009 | EP2043692A2 Polysaccharide derivatives of erythropoietin |
| 04/08/2009 | EP2043679A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 04/08/2009 | EP2043678A2 Caspase-8 and inflammation, infection and wound healing |
| 04/08/2009 | EP2043677A2 Combinations of human proteins to enhance viability of stem cells and progenitor cells |
| 04/08/2009 | EP2043676A2 Insulin-like growth factor-1 receptor antagonists |
| 04/08/2009 | EP2043675A2 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 04/08/2009 | EP2043674A1 Human growth and differentiation factor gdf-5 |
| 04/08/2009 | EP2043673A2 Use of soluble cd160 to suppress immunity |
| 04/08/2009 | EP2043672A2 Selective caspase inhibitors |
| 04/08/2009 | EP2043671A2 Method and compositions for treating stroke with fever |
| 04/08/2009 | EP2043666A2 Activated myeloid cells for promoting tissue repair and detecting damaged tissue |
| 04/08/2009 | EP2043650A2 Treatment for demyelinating disease |
| 04/08/2009 | EP2043632A2 New indications for direct thrombin inhibitors |
| 04/08/2009 | EP2043631A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/08/2009 | EP2043603A2 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 04/08/2009 | EP2043602A2 Cyclosporin compositions |
| 04/08/2009 | EP2043600A2 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 04/08/2009 | EP1896056A4 Reinforced collagen scaffold |
| 04/08/2009 | EP1814590B1 Treatment of obesity and related disorders |
| 04/08/2009 | EP1799248B1 Use of il-17f for the treatment and/or prevention of neurologic diseases |
| 04/08/2009 | EP1718667A4 Heterocyclic self-immolative linkers and conjugates |
| 04/08/2009 | EP1639007B1 Vegf traps and therapeutic uses thereof |
| 04/08/2009 | EP1519749B1 Chemotactic factor inhibitor for inhibiting inflammatory reactions |
| 04/08/2009 | EP1513811B1 Non-peptidic brs-3 agonists |
| 04/08/2009 | EP1482965B1 Method to control tumor progression and invasiveness |
| 04/08/2009 | EP1462518B1 Adipocyte differentiation-associated gene and protein |
| 04/08/2009 | EP1441708B1 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 04/08/2009 | EP1434600B1 Use of lh in controlled ovarian hyperstimulation |
| 04/08/2009 | EP1392722B1 Echinocandin process |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | EP1250353B1 P21 derived peptides capable of inhibiting cdk/cyclin complexes |
| 04/08/2009 | EP1130961B1 Stabilisation of milk from transgenic animals |
| 04/08/2009 | EP1096953B1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 04/08/2009 | EP1007569B1 Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitope |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | EP0861266B3 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 04/08/2009 | CN101405397A Fermentation processes |
| 04/08/2009 | CN101405298A Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 04/08/2009 | CN101405294A Compounds for enzyme inhibition |
| 04/08/2009 | CN101405023A Collagenase for treating cellulite |
| 04/08/2009 | CN101405022A Compositions and methods for oxalate reduction |
| 04/08/2009 | CN101405021A Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| 04/08/2009 | CN101405020A Endothelin and endothelin receptor agonists in the treatment of metabolic diseases |
| 04/08/2009 | CN101405018A Methods of preparing activated polymers having alpha nitrogen groups |
| 04/08/2009 | CN101405017A Chimeric proteins with phosphatidylserine binding domains |
| 04/08/2009 | CN101404981A Methods and compositions for treatment of diastolic heart failure |
| 04/08/2009 | CN101404980A Technology for preparation of macromolecular microspheres |
| 04/08/2009 | CN101404979A Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402688A Fusion protein, encoding gene and uses thereof |
| 04/08/2009 | CN101402681A Polypeptide from deer floral disc, preparing method and uses for preventing and treating diabetes |
| 04/08/2009 | CN101402680A Shark liver regeneration factor, preparation method and medical uses thereof |
| 04/08/2009 | CN101402676A Polyglycols modified disinfection/neutralization endotoxin polypeptide, preparation and uses thereof |
| 04/08/2009 | CN101402675A Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides |
| 04/08/2009 | CN101401933A Uses of FGFR2IIIc cell lateral segment in preparing medicament for preventing and treating spontaneous pulmonary fibrosis |
| 04/08/2009 | CN101401932A Injection for treating thrombus |
| 04/08/2009 | CN101401931A Detergent for removing dermatophytosis and abnormal smell of body |
| 04/08/2009 | CN101401930A Polypeptide and uses in preparing anti-heart failure and anti-inflammatory reaction medicament |
| 04/08/2009 | CN100475959C Coagulation factor VII anamorphosis |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475845C Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 04/08/2009 | CN100475844C Corticotropin releasing factor receptor 2 agonists |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475841C Process for preparing placental polypeptide for injection |
| 04/08/2009 | CN100475840C Wasp antibiotic peptide and preparing method and use thereof |
| 04/08/2009 | CN100475839C Inhibition peptide in domain of polymerase protein of hepatitis b virus, and application |
| 04/08/2009 | CN100475838C 10 peptide with cell protection function |
| 04/08/2009 | CN100475836C Mesenchymal stem cell affinity peptide screening and use |
| 04/08/2009 | CN100475757C Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome |
| 04/08/2009 | CN100475270C Medicine for treating tumor, and application thereof |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475266C Development of oviparous species by in ovo feeding |
| 04/08/2009 | CN100475264C Slow release microphere for injection containing interferon or its analog, and preparation method thereof |
| 04/08/2009 | CN100475231C Black soybean polysaccharides |
| 04/07/2009 | US7514547 Helicobacter felis vaccine |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514542 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 04/07/2009 | US7514536 interleukins produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; polypeptide has anti-hepatitis C activity |
| 04/07/2009 | US7514533 polypeptides and the nucleotide sequence from the encoding gene, used in the diagnosis, prevention, and treatment of diseases |
| 04/07/2009 | US7514532 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors |
| 04/07/2009 | US7514531 Specific binding sites in collagen for integrins and use thereof |
| 04/07/2009 | US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 04/07/2009 | US7514415 Suppressing an immune response in rheumatoid arthritis by administering a pure or isolated oligodeoxynucleotide of up to 100 nucleotides in length along with an additional antiinflammatory agent, immunosuppressive agent or antiarthritis agent |
| 04/07/2009 | US7514414 Autoimmune disease; bactericides, viricides, fungicides, parasiticides |
| 04/07/2009 | US7514413 Combination of ATP-depleting agents (mitochondrial ATP-inhibitor, a methylthioadenosine phosphorylase inhibitor or an inhibitor of De Novo purine synthesis); chemotherapy |
| 04/07/2009 | US7514409 VLA-4 antagonists |